ANDOVER RESEARCH EYE INSTITUTE Trademark

Trademark Overview


On Monday, May 16, 2022, a trademark application was filed for ANDOVER RESEARCH EYE INSTITUTE with the United States Patent and Trademark Office. The USPTO has given the ANDOVER RESEARCH EYE INSTITUTE trademark a serial number of 97412097. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, August 26, 2023. This trademark is owned by Ora, Inc.. The ANDOVER RESEARCH EYE INSTITUTE trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

business consulting services; marketing consulting services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; compilation and analysis of biostatistics for business or commercial purposes; business development services; advertising consulting services; public relations

medical and scientific research, namely, conducting clinical trials; pharmaceutical drug development services; pharmaceutical testing services
andover research eye institute

General Information


Serial Number97412097
Word MarkANDOVER RESEARCH EYE INSTITUTE
Filing DateMonday, May 16, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, August 26, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesbusiness consulting services; marketing consulting services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; compilation and analysis of biostatistics for business or commercial purposes; business development services; advertising consulting services; public relations
Goods and Servicesmedical and scientific research, namely, conducting clinical trials; pharmaceutical drug development services; pharmaceutical testing services

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, May 23, 2022
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 23, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOra, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAndover, MA 01810

Trademark Events


Event DateEvent Description
Monday, August 28, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, August 26, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, August 26, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, April 18, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, April 18, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, February 10, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, February 10, 2023FINAL REFUSAL E-MAILED
Friday, February 10, 2023FINAL REFUSAL WRITTEN
Thursday, January 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 26, 2022NON-FINAL ACTION E-MAILED
Tuesday, July 26, 2022NON-FINAL ACTION WRITTEN
Wednesday, July 13, 2022ASSIGNED TO EXAMINER
Monday, May 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 19, 2022NEW APPLICATION ENTERED